Leap Therapeutics
LPTX
LPTX
39 hedge funds and large institutions have $35.4M invested in Leap Therapeutics in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$249K | |
2 | +$247K | |
3 | +$201K | |
4 |
State Street
Boston,
Massachusetts
|
+$85K |
5 |
Morgan Stanley
New York
|
+$71.1K |
Top Sellers
1 | -$746K | |
2 | -$570K | |
3 | -$516K | |
4 |
Two Sigma Investments
New York
|
-$467K |
5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$206K |